Abstract
This review examines the antitumor activity and synthetic strategies for pyrrole-containing natural products possessing the oxygenated 3,4-diaryl or 3,4-diheteroaryl substitution pattern during the period of 1995–2005. The specific pyrrole-containing natural products are discussed in an order according to their characteristic structural features, which include the dihydroisoquinoline and δ-lactone framework in some cases. The presence or absence of methoxy or hydroxy groups at appropriate positions on aromatic rings or heteroaromatic rings is discussed and such factors have been correlated to antitumor activity and multidrug resistance reversal activity for various structural classes.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- DMFA:
-
N,N-dimethylformamide dimethylacetal
- DPPA:
-
Diphenylphosphorylazide
- ED50 :
-
Effective dose for 50% inhibition of cell culture growth
- MDR:
-
Multi drug resistance
- MIC:
-
Minimum inhibitory concentration
- PTSA:
-
p-Toluenesulfonic acid
References
Newman DJ, Cragg GM, Snader KM (2003) J Nat Prod 66:1022
Schwartsmann G, Rocha A, Mattei J, Lopes RM (2003) Expert Opin Inv Drug 12:1367
Urban S, Hickfod S, Blunt J, Munro M (2000) Curr Org Chem 4:765
Kuramaoto M, Arimoto H, Uemura D (2004) Mar Drugs 2:39
Fernandez D, Ahaidar A, Danelon G, Cironi P, Marfil M, Perez O, Cuevas C, Albericio F, Joule J, Alvarez M (2004) Monat Chem 135:615
Yoshida W, Lee K, Carroll A, Scheuer P (1992) Helv Chim Acta 75:1721
Davidson B (1993) Chem Rev 93:1771
Furstner A, Weintritt H, Hupperts A (1995) J Org Chem 60:6637
Banwell M, Flynn B, Hamel E, Hockless D (1997) Chem Commun 2:207
Boger D, Boyce C, Labroli M, Sehon C, Jin Q (1999) J Am Chem Soc 121:54
Gupton J, Krumpe K, Burnham B, Webb T, Shuford J, Sikorski J (1999) Tetrahedron 55:14515
Kim S, Son S, Kang H (2001) Bull Korean Chem Soc 22:1403
Burnham B, Gupton J, Krumpe K, Webb T, Shuford J, Bowers B, Warren A, Barnes C, Hall I (1998) Arch Pharm Pharm Med Chem 331:337
Gupton J, Burnham B, Byrd B, Krumpe K, Stokes C, Shuford J, Winkle S, Webb T, Warren A, Barnes C, Henry J, Hall I (1999) Pharmazie 54:691
Gupton J, Burnham B, Krumpe K, Du K, Sikorski J, Warren A, Barnes C, Hall I (2000) Arch Pharm Pharm Med Chem 333:3
Evans M, Smith D, Holub J, Argenti A, Hoff M, Daiglish G, Wilson D, Taylor B, Berkowitz J, Burnham B, Krumpe K, Gupton J, Scarlett T, Durham R, Hall I (2003) Arch Pharm Pharm Med Chem 336:1
Bullington J, Wolff R, Jackson P (2002) J Org Chem 67:9439
Liu J, Yang Q, Mak T, Wong H (2000) J Org Chem 65:3587
Andersen R, Faulkner J, Cun-heng H, Van Duyne G, Clardy J (1985) J Am Chem Soc 107:5492
Bailly C (2004) Cur Med Chem–Anti-Cancer Agents 4:363
Dias N, Vezin H, Lansiaux A, Bailly C (2005) Top Curr Chem 253:89
Marco E, Laine W, Tardy C, Lansiaux A, Iwao M, Ishibashi F, Bailly C, Gago F (2005) 48:3796
Tardy C, Facompre M, Laine W, Baldeyrou B, Gravalos D, Francesch A, Mateo C, Pastor A, Jimenez J, Manzanares I, Cuevas C, Bailly C (2004) Bioorg Med Chem 12:1697
Facompre M, Tardy C, Bal-Mahieu C, Colson P, Perez C, Manzanares I, Cuevas C, Bailly C (2003) Cancer Res 63:7392
Reddy M, Rao M, Rhodes D, Hansen M, Rubins K, Bushman F, Venkateswarlu Y, Faulkner J (1999) J Med Chem 42:1901
Ishibashi F, Tanabe S, Oda T, Iwao M (2002) J Nat Prod 65:500
Quesada A, Gravalos M, Puentes F (1996) Brit J Cancer 74:677
Vanhuyse M, Kluza J, Tardy C, Otero G, Cuevas C, Bailly C, Lansiaux A (2005) Cancer Lett 221:165
Heim A, Terpin A, Steglich W (1997) Angew Chem Int Ed Engl 36:155
Peschko C, Winklhofer C, Steglich W (2000) Chem Eur J 6:1147
Banwell M, Flynn B, Hockless D (1997) Chem Commun 23:2259
Banwell M, Flynn B, Hockless D, Longmore R, Rae D (1998) Aust J Chem 52:755
Ruchirawat S, Mutarapat T (2001) Tetrahedron Lett 42:1205
Ploypradith P, Jinajlueng W, Pavaro C, Ruchirawat S (2003) Tetrahedron Lett 44:1363
Ploypradith P, Mahidol C, Sahakitpichna P, Wongbundit S, Ruchirawat S (2004) Angew Chem Int Ed 43:866
Diaz M, Guitian E, Castedo L (2001) Synlett 7:1164
Iwao M, Takeuchi T, Fujikawa N, Fukuda T, Ishibashi F (2003) Tetrahedron Lett 44:4443
Handy S, Zhang Y, Bregman H (2004) J Org Chem 69:2362
Handy S, Zhang Y (2005) Org Prep Proc Int 37:411
Olsen C, Parera N, Albericio F, Alvarez M (2005) Tetrahedron Lett 46:2041
Cironi P, Manzanares I, Albericio F, Alvarez M (2003) Org Lett 5:2959
Marfil M, Albericio F, Alvarez M (2004) Tetrahedron 60:8659
Ploypradith P, Kagan R, Ruchirawat S (2005) J Org Chem 70:5119
Kang H, Fenical W (1997) J Org Chem 62:3254
Chan G, Francis T, Thureen D, Offen P, Pierce N, Westley J, Johnson R, Faulkner J (1993) J Org Chem 58:2543
Boger D, Soenen D, Boyce C, Hedrick M, Jin Q (2000) J Org Chem 65:2479
Tao H, Hwang I, Boger D (2004) Bioorg Med Chem Lett 14:5979
Gupton J, Clough S, Miller R, Lukens J, Henry C, Kanters R, Sikorski J (2003) Tetrahedron 59:207
Peschko C, Steglich W (2000) Tetrahedron Lett 41:9477
Namsa-aid A, Ruchirawat S (2002) Org Lett 4:2633
Hamasaki A, Zimpleman J, Hwang I, Boger D (2005) J Am Chem Soc 127:10767
Rudi A, Goldberg I, Stein Z, Frolow F, Benayahu Y, Schleyer M, Kashman Y (1994) J Org Chem 59:999
Loya S, Rudi A, Kashman Y, Hizi A (1999) Biochem J 344:85
Rudi A, Evan Y, Aknin M, Kashman Y (2000) J Nat Prod 63:832
Kreipl A, Reid C, Steglich W (2002) Org Lett 4:3287
Gupton J, Miller R, Krumpe K, Clough S, Banner E, Kanters R, Du K, Keertikar K, Lauerman N, Solano J, Adams B, Callahan D, Little B, Scharf A, Sikorski J (2005) Tetrahedron 61:1845
Palermo J, Rodriguez B, Florencia M, Seldes A (1996) Tetrahedron 52:2727
Furstner A, Krause H, Thiel O (2002) Tetrahedron 58:6373
Frode R, Hinze C, Josten I, Schmidt B, Steffan B, Steglich W (1994) Tetrahedron Lett 35:1689
Hoshino T, Kojima Y, Hayashi T, Uchiyama T, Kaneko K (1993) Biosci Biotech Biochem 57:775
Kashman Y, Goldshlager G, Gravalos M, Schleyer M (1999) Tetrahedron Lett 40:997
Heinrich M, Steglich W, Banwell M, Kashman Y (2003) Tetrahedron 59:9239
Banwell M, Bray A, Edwards A, Wong D (2002) J Chem Soc Perkin Trans 1 11:1340
Warabi K, Matsunaga S, van Soest R, Fusetani N (2003) J Org Chem 68:2765
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Gupton, J.T. Pyrrole Natural Products with Antitumor Properties. In: Lee, M. (eds) Heterocyclic Antitumor Antibiotics. Topics in Heterocyclic Chemistry, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7081_019
Download citation
DOI: https://doi.org/10.1007/7081_019
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30982-6
Online ISBN: 978-3-540-37650-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)